A Prospective, Randomized, Controlled Study of rhTPO in Combination With Herombopag + CsA vs Herombopag + CsA for the Treatment of Primary TD-NSAA
Clinical trial NCT06004791 · UNKNOWN
Trial details
- NCT number
- NCT06004791
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2024-08-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.